Open | - |
Close | - |
Volume / Avg. | 0 / 944.434K |
Day Range | - - - |
52 Wk Range | 13.290 - 47.735 |
Market Cap | $3.240B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 11.29% |
Days to Cover | 10.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of IDEAYA Biosciences (NASDAQ: IDYA) through any online brokerage.
Other companies in IDEAYA Biosciences’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and Arrowhead Pharma (NASDAQ:ARWR).
The latest price target for IDEAYA Biosciences (NASDAQ: IDYA) was reported by BTIG on Friday, March 8, 2024. The analyst firm set a price target for 55.00 expecting IDYA to rise to within 12 months (a possible 26.55% upside). 24 analyst firms have reported ratings in the last year.
The stock price for IDEAYA Biosciences (NASDAQ: IDYA) is $43.46 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for IDEAYA Biosciences.
IDEAYA Biosciences’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for IDEAYA Biosciences.
IDEAYA Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.